CRISPR Therapeutics AG (CRSP)
55.03
-1.11
(-1.98%)
USD |
NASDAQ |
Apr 19, 16:00
54.90
-0.13
(-0.24%)
After-Hours: 19:10
CRISPR Therapeutics Accrued Comprehensive Inc (Quarterly)
Accrued Comprehensive Inc (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accrued Comprehensive Inc (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
Date | Value |
---|---|
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
June 30, 2016 | -- |
December 31, 2015 | -- |
Comprehensive Income Definition
Comprehensive Income is the sum of Net Income and other income statement items gains/losses that have not been realized. This may include items such as unrealized gains/losses on securities / transactions or foreign currency gains / losses. Comprehensive Income may be reported in a separate statement called Owners Change in Equity.